Jenscare Scientific
Focuses on R&D, production, sales and service in the field of minimally invasive valve interventional therapy, and strives to provide innovative solutions for doctors and patients.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
* | N/A | HKD225m | IPO |
| Total Funding | 000k | ||
| CNY | 2020 | 2021 | 2022 | 2023 | 2024 | 2027 |
|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Equity research estimates
Related Content
Jenscare is a medical technology company specializing in the development of advanced heart valve solutions. The company focuses on creating innovative and effective treatments for patients with heart valve diseases, aiming to improve their quality of life. Jenscare operates in the healthcare market, primarily serving hospitals, clinics, and medical professionals who require reliable and cutting-edge cardiac care solutions. The business model revolves around the research, development, and commercialization of heart valve products, generating revenue through the sale of these medical devices. Jenscare's commitment to safety and efficacy is reflected in its continuous efforts to meet customer needs and uphold high standards in medical treatment.
Keywords: heart valve solutions, medical technology, cardiac care, patient safety, treatment efficacy, healthcare market, hospitals, clinics, medical professionals, innovative treatments.
